(R)-(+)-阿替洛尔
|
|
|
- CAS号:
- 56715-13-0
- 英文名:
- (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE
- 英文别名:
- (+)-Atenolol;(R)-(+)-ATENOLOL;Atenolol R-Isomer;(R)-(+)-AtenololHCl;(R)-(+)-Atenolol 99%;R(+)-ATENOLOL LESS ACTIVE ENANTIOME;Atenolol Impurity 15 ((R)-Atenolol);(R)-2-(4-(2-hydroxy-3-(isopropylaMino)propoxy)phenyl)acetaMide;2-[4-[(2R)-2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide;4-[(R)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
- 中文名:
- (R)-(+)-阿替洛尔
- 中文别名:
- 阿替洛尔R-异构体;(R)-(+)-阿替洛尔;(R)-(+)-氨酰心安;(R)-(+)-阿替洛尔盐酸盐;阿替洛尔杂质15 ((R)-阿替洛尔);(+)-4-[2-羟基-3-[(1-甲基乙基)氨基]丙氧基]苯乙酰胺
- CBNumber:
- CB4230500
- 分子式:
- C14H22N2O3
- 分子量:
- 266.34
- MOL File:
- 56715-13-0.mol
|
|
|
(R)-(+)-阿替洛尔化学性质
-
熔点:
-
148-152 °C(lit.)
-
|
-
沸点:
-
508.0±50.0 °C(Predicted)
-
|
-
密度:
-
1.125±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: >6.0 mg/mL
-
|
-
酸度系数(pKa):
-
13.88±0.20(Predicted)
-
|
-
形态:
-
solid
-
|
-
颜色:
-
pale yellow
-
|
-
旋光性 (optical activity):
-
[α]25/D +16°, c = 1 in 1 M HCl
-
|
(R)-(+)-阿替洛尔性质、用途与生产工艺
(R)-(+)-Atenolol 是活性较低的 (R,S)-atenolol 的对映体。(R,S)-atenolol 是 β-肾上腺素能受体拮抗剂。
(R)-(+)-阿替洛尔
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/11/08 | HY-B2111 | (R)-(+)-阿替洛尔
(R)-(+)-Atenolol | 56715-13-0 | 5mg | 600元 |
| 2024/11/08 | HY-B2111 | (R)-(+)-阿替洛尔
(R)-(+)-Atenolol | 56715-13-0 | 10mM * 1mLin DMSO | 660元 |
56715-13-0, (R)-(+)-阿替洛尔 相关搜索:
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Aromatics
- Amines
- 杂质对照品
- 小分子抑制剂
- Organic Building Blocks
- Asymmetric Synthesis
- Chiral Building Blocks
- Amino Alcohols
- CH32CHNHCH2CHOHCH2OC6H4CH2CONH2
- 阿替洛尔杂质15 ((R)-阿替洛尔)
- (R)-(+)-氨酰心安
- (R)-(+)-阿替洛尔盐酸盐
- 阿替洛尔R-异构体
- (R)-(+)-阿替洛尔
- (+)-4-[2-羟基-3-[(1-甲基乙基)氨基]丙氧基]苯乙酰胺
- 56715-13-0
- Prenormin,2-[4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
- Atenolol Impurity 15 ((R)-Atenolol)
- (+)-Atenolol
- (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE
- (+)-2-[4-[(2R)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy] phenyl] acetamide
- (R)-(+)-AtenololHCl
- (R)-(+)-ATENOLOL
- (R)-(+)-Atenolol 99%
- Atenolol R-Isomer
- (R)-2-(4-(2-hydroxy-3-(isopropylaMino)propoxy)phenyl)acetaMide
- 4-[(2R)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzeneacetaMide
- Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, (R)-
- Benzeneacetamide, 4-[(2R)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]-
- R(+)-ATENOLOL LESS ACTIVE ENANTIOME
- (R)-(+)-Atenolol,(+)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
- 2-[4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]ethanamide
- 2-[4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
- 2-[4-[(2R)-2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide
- 4-[(R)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide